What top creators are saying about Pango Therapeutics(PGTX)
Biotechnology company that has seen significant recent stock price appreciation.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Pango Therapeutics in the last 30 days yet.
Top creators covering Pango Therapeutics (PGTX)
The 1 sources with the most insights about Pango Therapeutics on Kazuha.
Latest insights about Pango Therapeutics (PGTX)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Thursday, September 11, 2025
A 10% owner (Third Rock Ventures) with a very good track record of timing sales has made their largest individual sales ever after the stock ran up 250%, suggesting a notable bearish outlook.
Thursday, September 11, 2025
A 10% owner (Third Rock Ventures) with a very good track record of timing sales has made their largest individual sales ever after the stock ran up 250%, suggesting a notable bearish outlook.
Discussed alongside Pango Therapeutics (PGTX)
Other assets that creators frequently mention in the same content as Pango Therapeutics.
Frequently asked
Which podcasters and creators cover Pango Therapeutics (PGTX) the most?
The most active sources covering Pango Therapeutics (PGTX) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Pango Therapeutics (PGTX) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Pango Therapeutics (PGTX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Pango Therapeutics (PGTX)?
Creators covering Pango Therapeutics (PGTX) most frequently also discuss MDU, ANET, DLTR, DHI, CRIS. See the "Discussed alongside" section above for full asset pages.